conferenceseries.com drug design & drug formulation · welcome message to the participants in...
TRANSCRIPT
October 19-20, 2017 Seoul, South Korea
conferenceseries.com
www.drugformulation-bioavailability.pharmaceuticalconferences.com
Participation200+ 15+ 10+ 50+ 3+ 10+ B2B
InteractiveSessions
KeynoteLectures
PlenaryLectures
Exhibitors MeetingsWorkshops
9th Annual Congress on
Drug Design & Drug Formulation
Media Partners
www.drugformulation-bioavailability.pharmaceuticalconferences.com
www.drugformulation-bioavailability.pharmaceuticalconferences.com
Keynote SpeakersJames David AdamsAsst. Professor, University of Southern California, USA
Biography: Dr. Adams received his PhD from UC San Francisco in 1981 in Pharmacology and Toxicology. His postdoctoral experience was at Baylor College of Medicine in Houston, Texas and the National Institutes of Health in Bethesda, Maryland. He served as a research assistant professor at Washington State University before coming to USC School of Pharmacy in 1987.
Kenneth KChair and Director of Hematology Division, Taiwan
Biography: Kenneth K. Wu received MD from National Taiwan University, Taipei, Taiwan, M.S. from Yale University New Haven, CT, USA and PhD in pharmacology from University of London, UK. He was Huffington Chair and Director of Hematology Division at University of Texas Health Science Center at Houston; Distinguished Investigator and Former President of National Health Research Institutes (NHRI), Taiwan. He is currently distinguished professor and director of Metabolomic Medicine Research Center at CMU, Taiwan. He holds Ho Jin Dui Chair at NTHU and Distinguished Chair at National Taiwan University, Taiwan. His research interests have centered on thrombosis, vascular biology and prostaglandin synthesis and regulation. He is a member of several distinguished academic societies and has received international recognitions and awards. His group has recently discovered 5-MTP as an innate anti-inflammatory molecule and a new member of arsenal against systemic inflammation and cancer metastasis.
Welcome MessageWelcome message to the participants in Drug Formulation 2017.It is a pleasure to welcome all of the participants to Drug Formulation 2017 in Seoul, South Korea. Clearly, this will be a large and stimulating meeting
with many presentations from a broad spectrum of topics concerning drug formulation and drug design. The conference will focus on advanced drug formulation and drug design techniques that optimize therapeutic outcomes. I will participate in every aspect of the meeting and look forward to many enthusiastic discussions. The meeting will provide opportunities to meet colleagues from around the world, to discuss collaboration and to share new approaches to therapeutic challenges. We will also enjoy the hospitality of the people of Seoul, the beauty of the city and of South Korea. I will see you at the meeting.
James David AdamsAssociate Professor
University of Southern California, USA
www.drugformulation-bioavailability.pharmaceuticalconferences.com
Keynote SpeakersJames David AdamsAsst. Professor, University of Southern California, USA
Biography: Dr. Adams received his PhD from UC San Francisco in 1981 in Pharmacology and Toxicology. His postdoctoral experience was at Baylor College of Medicine in Houston, Texas and the National Institutes of Health in Bethesda, Maryland. He served as a research assistant professor at Washington State University before coming to USC School of Pharmacy in 1987.
Kenneth KChair and Director of Hematology Division, Taiwan
Biography: Kenneth K. Wu received MD from National Taiwan University, Taipei, Taiwan, M.S. from Yale University New Haven, CT, USA and PhD in pharmacology from University of London, UK. He was Huffington Chair and Director of Hematology Division at University of Texas Health Science Center at Houston; Distinguished Investigator and Former President of National Health Research Institutes (NHRI), Taiwan. He is currently distinguished professor and director of Metabolomic Medicine Research Center at CMU, Taiwan. He holds Ho Jin Dui Chair at NTHU and Distinguished Chair at National Taiwan University, Taiwan. His research interests have centered on thrombosis, vascular biology and prostaglandin synthesis and regulation. He is a member of several distinguished academic societies and has received international recognitions and awards. His group has recently discovered 5-MTP as an innate anti-inflammatory molecule and a new member of arsenal against systemic inflammation and cancer metastasis.
Welcome MessageWelcome message to the participants in Drug Formulation 2017.It is a pleasure to welcome all of the participants to Drug Formulation 2017 in Seoul, South Korea. Clearly, this will be a large and stimulating meeting
with many presentations from a broad spectrum of topics concerning drug formulation and drug design. The conference will focus on advanced drug formulation and drug design techniques that optimize therapeutic outcomes. I will participate in every aspect of the meeting and look forward to many enthusiastic discussions. The meeting will provide opportunities to meet colleagues from around the world, to discuss collaboration and to share new approaches to therapeutic challenges. We will also enjoy the hospitality of the people of Seoul, the beauty of the city and of South Korea. I will see you at the meeting.
James David AdamsAssociate Professor
University of Southern California, USA
www.drugformulation-bioavailability.pharmaceuticalconferences.com
Keynote SpeakersJames David AdamsAsst. Professor, University of Southern California, USA
Biography: Dr. Adams received his PhD from UC San Francisco in 1981 in Pharmacology and Toxicology. His postdoctoral experience was at Baylor College of Medicine in Houston, Texas and the National Institutes of Health in Bethesda, Maryland. He served as a research assistant professor at Washington State University before coming to USC School of Pharmacy in 1987.
Kenneth KChair and Director of Hematology Division, Taiwan
Biography: Kenneth K. Wu received MD from National Taiwan University, Taipei, Taiwan, M.S. from Yale University New Haven, CT, USA and PhD in pharmacology from University of London, UK. He was Huffington Chair and Director of Hematology Division at University of Texas Health Science Center at Houston; Distinguished Investigator and Former President of National Health Research Institutes (NHRI), Taiwan. He is currently distinguished professor and director of Metabolomic Medicine Research Center at CMU, Taiwan. He holds Ho Jin Dui Chair at NTHU and Distinguished Chair at National Taiwan University, Taiwan. His research interests have centered on thrombosis, vascular biology and prostaglandin synthesis and regulation. He is a member of several distinguished academic societies and has received international recognitions and awards. His group has recently discovered 5-MTP as an innate anti-inflammatory molecule and a new member of arsenal against systemic inflammation and cancer metastasis.
Welcome MessageWelcome message to the participants in Drug Formulation 2017.It is a pleasure to welcome all of the participants to Drug Formulation 2017 in Seoul, South Korea. Clearly, this will be a large and stimulating meeting
with many presentations from a broad spectrum of topics concerning drug formulation and drug design. The conference will focus on advanced drug formulation and drug design techniques that optimize therapeutic outcomes. I will participate in every aspect of the meeting and look forward to many enthusiastic discussions. The meeting will provide opportunities to meet colleagues from around the world, to discuss collaboration and to share new approaches to therapeutic challenges. We will also enjoy the hospitality of the people of Seoul, the beauty of the city and of South Korea. I will see you at the meeting.
James David AdamsAssociate Professor
University of Southern California, USA
Organizing Committee Members
www.drugformulation-bioavailability.pharmaceuticalconferences.com
Riccardo PanicucciVice PresidentWuXiAppTec
USA
Peng LiScientist,
MedicineUniversity of California, USA
Weiguo DaiScientific Director
Johnson and JohnsonUSA
James David AdamsAssociate Professor
University of Southern Californi, USA
Robert P. BorrisProfessor
Tianjin UniversityChina
Abdulmohsen H. Alrohaimi
Dean, Shaqra University, Saudi Arabia
Anju DhimanAssistant Professor
Maharshi Dayanand University, India
Peter MaienfischProfessor
East China Institute of Science & Technology,China
Anand KulkarniDirector & Head of
Formulation DevelopmentBio Duro- LLC, China
Didem KartAssociate Professer
Hacettepe UniversityTurkey
Confirmed Speakers
Oral PresentationsTitle: Oral pain killers are killing people: there is a better way.James D Adams, PhD, USC School of Pharmacy, USATitle: Formulation development for enhanced anti-inflammatory effect of Eugenol using transdermal solid lipid nanoparticleAbdulmohsen H. Al Rohaimi, Gulam Mustafa ,College of pharmacy, Saudi Arabia.Title: Foam- A Unique Topical Drug Delivery System D TAMARKIN PhD, Foamix Pharmaceuticals Ltd., IsraelD TAMARKIN PhD, Foamix Pharmaceuticals Ltd., IsraelTitle: Transition metal complexes/organometallic compounds as anticancer/anti HIV drugs or in pharmaceutical industryPrakash Kinthada Sri Vidyanikethan Engineering college, IndiaTitle: Heavy Metal Content and Potential Health Risk of Geophagic White Clay from the Kumasi Metropolis in GhanaMavis Korankye, PhD researcher, Dongguk University, South KoreaTitle: Content of Ginsenoside Rg1 in the Panax ginseng cultivated in MongoliaBayaraa.S, Bayanmunkh.A, Drug Research Institute, Mongolia1Title: Identification of Bifidobacterium Animalis Ssp. Lactis from Egyptian Women Breast Milk and Feces of Breast Fed Infant Based on Molecular LevelAli M Awaad1, faculty of Agricultural Al-Azhar University, Egypt Title: A Multicenter, Time Series Clinical Trial Comparing Indirect Magnesium Chelating Agents with Everolimus in Renal Cell SarcomasJeff Rogers, University of Massachusetts., USA Title: Scientific and Regulatory Considerations on Manufacturing, Process, and Controls of Complex Liposomal Drug ProductsMaotang Zhou, PhD, U.S. Food and Drug Administration (FDA), USA
www.drugformulation-bioavailability.pharmaceuticalconferences.com
Title: Synthesis, characterization, antimicrobial and antioxidant activities of a (18)-annulene derivative incorporating three thienocoumarin fragmentsEmmanuel Sopbue Fondjoa, aLaboratory of Applied Synthetic Organic Chemistry, Cameroon Title: Design of HDAC 2 Inhibitors based on molecular modelling Geetha Ramakrishnan, Sathyabama University, ChennaiTitle: Fast Dissolving Drug Delivery Systems.Gulay Yelken Demırel, R&D Project Group Executive, Sanovel Pharmaceuticals, TurkeyTitle: Interchangeability Of Medicines Using Metformin As A Surrogate Product (Ii)Kolawole Jacob, University of Jos. Nigeria.Title: Synthesis and characterization of aptamer-navigated drug loaded polymeric micro-particles for enhanced targeted deliveryTan Kei Xian, Curtin University, MalaysiaTitle: Dissolution enhancement of Aceclofenac tablet by solid dispersion techniqueKiroj Rajbanshi1, Kathmandu University, Dhulikhel, NepalTitle: Comparative Study In Preservation Efficiency Of Oral Calcium/Vitamin D3/Vitamin B12 SyrupMostafa E. Eissa, MSc, HIKMA Pharma, EgyptTitle: Hot Melt Extrusion An Emerging Drug Delivery TechnologyRashid Mahmood Surge Laboratories Private Limited Pakistan.Title: A Rapid Hydrophilic Interaction Liquid Chromatographic Determination of Glimepiride in Pharmaceutical FormulationsYuegang Zuo1, University of Michigan, USA
Award Ceremony & Closing Ceremony
www.drugformulation-bioavailability.pharmaceuticalconferences.com
* Exclusive Exhibitor Event | ** Networking EventNote: Conference schedule is subject to change.Note: Workshops and Symposia slots are available. To book slot for Workshop and Symposium send us the proposal.
Ten
tative
Age
nda October 19, 2017 Thursday
Time Session08:30-09:30 Registrations09:30-11:00 Keynote Forum
Group Photo11:00-11:15 Network & Refreshments Break11:15-13:00 Track 1: Rational Drug design | Track 2: Computer Aided Drug Design13:00-13:45 Lunch Break13:45-16:00 Track 3: Molecular Modelling in Drug Designing | Track 4: Biomarkers in Drug Design16:00-16:15 Network & Refreshments Break16:15-18:00 Track 5: Perspectives in Drug Discovery | Track 6: Pre-Formulation & Formulation Aspects | Track 7: Traditional Medicine
October 20, 2017 FridayTime Session
08:30-09:30 Registrations09:30-11:30 Keynote Forum
10:30-11:30 Track8: Types of Formulations| Track 9: Drug Formulation Procedures | Methodological Advancements inPharmaceutical Industries
11:30-11:45 Network & Refreshments Break11:45-13:00 Track 10: Pharmacokinetics and Pharmacodynamics13:00-13:45 Lunch Break13:45-15:00 Track 11: Clinical Trails & Biotherapeutics | Pharmaceutical Engineering15:00-15:15 Network & Refreshments Break15:15-16:30 Track 12: Pharmaceutical Nanotechnology | Medicinal Chemistry16:30-18:00 Poster Presentations
Award CeremonyConference Concludes
www.drugformulation-bioavailability.pharmaceuticalconferences.com
Some Renowed Speakers Journals
www.drugformulation-bioavailability.pharmaceuticalconferences.com
Abdulmohsen H. Al Rohaimi
James David Adhams
Ali M Awaad
Mostafa Essam Eissa
GeethaRamakrishnan
Movis korenky
Jacob Kolawale
Prakash Kinthada Many More...
Glimpses of past conference
www.drugformulation-bioavailability.pharmaceuticalconferences.com
Tourist Attractions
www.drugformulation-bioavailability.pharmaceuticalconferences.com
Seoul Special City is the capital and largest metropolis of the Republic of Korea (commonly known as South Korea), forming the heart of the Seoul Capital Area, which includes the surrounding Incheon metropolis and Gyeonggi province, the world’s 16th largest city. It is home to over half of all South Koreans along with 678,102 international residents.Situated on the Han River, Seoul’s history stretches back more than two thousand years when it was founded in 18 BCE by Baekje, one of the Three Kingdoms of Korea
Seoul, the capital of South Korea, is a colossal city where cutting edge high rises and neon lights to Buddhist sanctuaries, royal residences and pagodas, Seoul is a captivating blend of old and new. A center point of business, culture and back both inside South Korea and globally, Seoul houses the base camp for a portion of the world’s biggest organizations. It likewise has one of the world’s best tram frameworks – the most straightforward approach to get around in this thickly populated range. For the best perspective of the city, go to the tower on Namsan, one of the mountains that encompass the city. Seoul is viewed as a main and rising worldwide city. Seoul is encompassed by mountains, the tallest being Mt. Bukhan, the world’s most went by national park per square foot. Present day points of interest incorporate the famous N Seoul Tower, the gold-clad 63 Building, the neofuturistic Dongdaemun Design Plaza, Lotte World, the world’s second biggest indoor amusement park, Moonlight Rainbow Fountain, the world’s longest extension wellspring and the Sevit Floating Islands. Soul is the world’s ninth most gone to city and fourth biggest worker in tourism. Remarkable attractions incorporate advanced Dongdaemun Design Plaza, a tradition lobby with bending engineering and a housetop park; Gyeongbokgung Palace and Jogyesa Temple.
You’ll fall in love with Seoul South Korea
Venue:Hotel Novetal Dokson
Seoul, South Korea
Mail us to know more!For Abstract Submission Guidelines | For Reserving your slot | Proposals | Registration | Posters | Accommodations
No doubt you have lots of queries... Why not get in touch..!
Drop us your query with details and we will call you right away
Venue
For Queries Contact: Monty Karl | Program Manager
Email: [email protected] Ph: +1-702-508-5200 Ext: 8046
Toll No: +1-800-216-6499 (USA & Canada)
For Exhibition & Sponsorship Monty Karl
Email: [email protected]
Hosted by Conference Series Ltd. 57 Ullswater Avenue, West End
Southampton, HampshireUnited Kingdom, SO 183QSToll Free: +1800-216-6499
http://drugformulation-bioavailability.pharmaceuticalconferences.com/
http://drugformulation-bioavailability.pharmaceuticalconferences.com